July 17, 2017 10:00 AM EDT
R&D
Pharma

FDA's Scott Got­tlieb is field­ing a new team of re­cruiters to start scout­ing top tal­ent

John Carroll

Editor & Founder

Biotech ex­ecs have been bull­ish sup­port­ers of the FDA in re­cent years, of­fer­ing their ap­pre­ci­a­tion of faster re­view times with new pro­grams like the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times